Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Poland / NCT07170956
Active, not recruiting Observational

Analysis of Tooth Root Number

NCT07170956 · tracked via the Priya Life Science Poland tracker
Sponsor
Hospital of the Ministry of Interior, Kielce, Poland
Phase
Observational
Started
2025-09-01
Last updated
2026-07-10

Condition(s) studied

Tooth AbnormalitiesTooth AbnormalityTooth AnatomyTooth Development DisorderTooth Disorder

Study summary

The aim of this cross-sectional study is to assess the number of roots in permanent teeth. For this reason, researchers will conduct an analysis of CBCT scans. The collected data will be used for epidemiological analysis, including an examination of differences in outcomes between male and female patients.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * CBCT scans obtained following a written referral from a dentist, * clear and complete visibility of the assessed structure, * completed development of assessed roots. Exclusion Criteria: * incomplete root development in teeth other than third molars within the dentition, * CBCT scans with significant artefacts.

Primary outcome measure(s)

  • Tooth root number — The assessment is conducted once at the time of enrolment
    Number of separate roots of a single tooth, regardless of the level of division

Trial sites (1)

FacilityCityRegionStatus
Department of Maxillofacial Surgery, Hospital of the Ministry of Interior Kielce Poland

More Hospital of the Ministry of Interior, Kielce, Poland trials in Poland

Anatomical and Imaging Assessment of the Alveolar Antral Artery Canal Using CBCT Recruiting
Large Language Models for Dental Radiology Report Generation From Structured Textual Data Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07170956 on ClinicalTrials.gov ↗ ← All trials in Poland